| (Values in U.S. Thousands) | Oct, 2024 | Oct, 2023 | Oct, 2022 | Oct, 2021 | Oct, 2020 |
| Sales | 3,895,400 | 3,593,200 | 3,308,400 | 2,922,500 | 2,430,900 |
| Sales Growth | +8.41% | +8.61% | +13.20% | +20.22% | -8.39% |
| Net Income | 392,300 | 294,200 | 385,800 | 2,944,700 | 238,400 |
| Net Income Growth | +33.34% | -23.74% | -86.90% | +1,135.19% | -48.92% |
Cooper Companies (COO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
83.77 -1.21 (-1.42%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 83.77 unch (unch) 16:20 ET
for Fri, Mar 28th, 2025
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.'CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Fiscal Year End Date: 10/31